³Ô¹ÏÍøÕ¾

Latest colorectal cancer News

Cancer while pregnant is rare, but is becoming more common. Here’s what researchers think is behind the rise
Increased medicines access continues following budget boost
Bowel Cancer Breakthrough
Too much lactate can harm our health – these microbes in our gut keep it in check
Metabolic Syndrome Linked To Bowel Cancer
For 50,000 Australians October 5 is the one day each year when they can be seen and heard
$5m Grant Supports Colorectal Cancer Research
The role alcohol plays in new cancer cases – landmark new report
Considering race in colon cancer prediction reduces disparities
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Asbestos study highlights risk of ACT residents developing cancer
The Princess of Wales wants to stay cancer-free. What does this mean?
Hon Dr Shane Reti: ³Ô¹ÏÍøÕ¾ delivers first cancer medicines from $604m boost
New knowledge about cell receptors paves the way for new drugs against intestinal tumours
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
Caroline Nordenvall awarded twice at the Surgeons’ Week 2024
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
Ground-breaking study reveals previously unknown genetic causes of colorectal cancer
Chimeric Therapeutics says first patient enrolled in cell therapy trial
³Ô¹ÏÍøÕ¾ Bowel Screening Programme reaches 2 million life-saving screening kits
Cutting Processed Meat Intake Brings Health Benefits
Nicotine In New Guise
Taking Measure Of ‘healthy’ Microbiome
Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
Promising Role Of Antidiabetic Drug In Cancer Control
Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment
How Research In Common Cancers Is Helping Rare Cancers
Identifying the initial steps in colorectal cancer formation
Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder
Exploring the effect of H2O2 eustress on individual cancer cells using hopping probe scanning ion conductance microscopy (HPICM)
Early onset bowel cancer on the rise
Gut microbiome: meet E coli – the infamous bacteria with an unfair reputation
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
Gut microbiome: meet Clostridium butyricum – the bacteria that helps keep us feeling our best
Silent cancers: here’s what you need to know when there are no obvious symptoms
Future Cancer Treatment And Fertility
Hamming it up: What’s the verdict on processed meat?
King Charles is having cancer treatment. What can he, and others with cancer, expect?
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Lab-grown tumours predict treatment outcomes in landmark study
Global cancer burden growing, amidst mounting need for services
Key to young onset bowel cancer may be gut bacteria
Cracking the code: How what you eat might affect your cancer risk
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Aggressive colon tumor may be vulnerable to cholesterol therapy
Even small amounts of physical activity could be valuable in late-stage lung cancer
Kate teaches ‘Art from heART’ to Mater patients
Wellcome Trust funds study of innate immune cells role in intestinal health and disease